{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:18Z","timestamp":1787019558632,"version":"build-2736575974"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The root cause of autoantibody formation against factor VIII (FVIII) in acquired hemophilia A (AHA) remains unclear. We aimed to assess whether AHA is exclusively associated with autoantibodies toward FVIII or whether patients also produce increased levels of autoantibodies against other targets. A case-control study was performed enrolling patients with AHA and age-matched controls. Human epithelial cell (HEp-2) immunofluorescence was applied to screen for antinuclear (ANA) and anticytoplasmic autoantibodies. Screening for autoantibodies against extractable nuclear antigens was performed by enzyme immunoassay detecting SS-A\/Ro, SS-B\/La, U1RNP, Scl-70, Jo-1, centromere B, Sm, double-stranded DNA, and \u03b1-fodrin (AF). Patients with AHA were more often positive for ANA than control patients (64% vs 30%; odds ratio [OR] 4.02, 1.98-8.18) and had higher ANA titers detected than controls. Cytoplasmic autoantibodies and anti-AF immunoglobulin A autoantibodies were also more frequent in patients with AHA compared with controls. Autoantibodies against any target other than FVIII were found in 78% of patients with AHA compared with 46% of controls (OR 4.16, 1.98-8.39). Results were similar preforming sensitivity analyses (excluding either subjects with autoimmune disorders, cancer, pregnancy, or immunosuppressive medication at baseline) and in multivariable binary logistic regression. To exclude that autoantibody staining was merely a result of cross-reactivity of anti-FVIII autoantibodies, we tested a mix of 7 well-characterized monoclonal anti-FVIII antibodies. These antibodies did not stain HEp-2 cells used for ANA detection. In conclusion, a diverse pattern of autoantibodies is associated with AHA, suggesting that a more general breakdown of immune tolerance might be involved in its pathology.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008071","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T11:22:24Z","timestamp":1660130544000},"page":"122-130","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01\/2010 study"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-0599","authenticated-orcid":false,"given":"Olga","family":"Oleshko","sequence":"first","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Werwitzke","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Klingberg","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[{"name":"2Department of Rheumatology and Clinical Immunology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Eichler","sequence":"additional","affiliation":[{"name":"3Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and Saarland University Hospital, Homburg\/Saar, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-8183","authenticated-orcid":false,"given":"Robert","family":"Klamroth","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, Vivantes Clinic Friedrichshain, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Holstein","sequence":"additional","affiliation":[{"name":"5Department of Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hart","sequence":"additional","affiliation":[{"name":"6Department of Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-7402","authenticated-orcid":false,"given":"Christian","family":"Pfrepper","sequence":"additional","affiliation":[{"name":"7Division of Hemostaseology, Medical Department I, University Hospital Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-7225","authenticated-orcid":false,"given":"Paul","family":"Kn\u00f6bl","sequence":"additional","affiliation":[{"name":"8Department of Hematology and Hemostasis, Vienna Medical University, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Greil","sequence":"additional","affiliation":[{"name":"9Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Salzburg, Austria"},{"name":"10Third Medical Department, Paracelsus Medical University Hospital, Salzburg, Austria"},{"name":"11Cancer Cluster Salzburg, Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Neumeister","sequence":"additional","affiliation":[{"name":"12Division of Hematology, Medical University, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-4610","authenticated-orcid":false,"given":"Birgit M.","family":"Reipert","sequence":"additional","affiliation":[{"name":"13IMC University of Applied Sciences, Krems, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-8536","authenticated-orcid":false,"given":"Andreas","family":"Tiede","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2023011217591401600_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"issue":"18","key":"2023011217591401600_bib2","first-page":"1861","article-title":"Prevention and management of bleeding episodes in patients with acquired hemophilia","volume":"78","author":"Kn\u00f6bl","year":"2018","journal-title":"A.\u00a0Drugs"},{"issue":"7","key":"2023011217591401600_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2014-07-587089","article-title":"Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01\/2010 study","volume":"125","author":"Tiede","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2023011217591401600_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.26009","article-title":"Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study","volume":"96","author":"Schep","year":"2021","journal-title":"Am J Hematol"},{"issue":"7","key":"2023011217591401600_bib5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"2023011217591401600_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0950-3536(96)80067-9","article-title":"Acquired inhibitors","volume":"9","author":"Cohen","year":"1996","journal-title":"Baillieres Clin Haematol"},{"key":"2023011217591401600_bib7","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor VIII: recent progress","volume":"10","author":"Lacroix-Desmazes","year":"2020","journal-title":"Front Immunol"},{"key":"2023011217591401600_bib8","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.3389\/fimmu.2019.03078","article-title":"Factor VIII: perspectives on Immunogenicity and Tolerogenic Strategies","volume":"10","author":"Scott","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"2023011217591401600_bib9","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1073\/pnas.89.9.3795","article-title":"Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals","volume":"89","author":"Algiman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2023011217591401600_bib10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2012-07-444877","article-title":"Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients","volume":"121","author":"Whelan","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2023011217591401600_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2014-09-598268","article-title":"Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans","volume":"125","author":"Hofbauer","year":"2015","journal-title":"Blood"},{"issue":"19","key":"2023011217591401600_bib12","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood-2015-09-672774","article-title":"Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01\/2010 study","volume":"127","author":"Tiede","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2023011217591401600_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2023011217591401600_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal Centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"2023011217591401600_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2019.04.007","article-title":"New players in the gene regulatory network controlling late B cell differentiation","volume":"58","author":"Willis","year":"2019","journal-title":"Curr Opin Immunol"},{"issue":"28","key":"2023011217591401600_bib16","doi-asserted-by":"crossref","first-page":"9727","DOI":"10.1073\/pnas.0803644105","article-title":"Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors","volume":"105","author":"Mietzner","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2023011217591401600_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41577-020-00454-2","article-title":"Rethinking peripheral T cell tolerance: checkpoints across a T cell\u2019s journey","volume":"21","author":"ElTanbouly","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2023011217591401600_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/cells10051190","article-title":"B\u00a0cell activation and escape of tolerance checkpoints: recent insights from studying autoreactive B cells","volume":"10","author":"Bonasia","year":"2021","journal-title":"Cells"},{"issue":"1","key":"2023011217591401600_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/imr.13053","article-title":"Silencing and activating anergic B cells","volume":"307","author":"Tanaka","year":"2022","journal-title":"Immunol Rev"},{"issue":"12","key":"2023011217591401600_bib20","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/eji.202048820","article-title":"Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases","volume":"50","author":"Reijm","year":"2020","journal-title":"Eur J Immunol"},{"key":"2023011217591401600_bib21","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3389\/fimmu.2018.01201","article-title":"CD8+HLADR+ regulatory T cells change with aging: they increase in number, but lose checkpoint inhibitory molecules and suppressive function","volume":"9","author":"Lukas Yani","year":"2018","journal-title":"Front Immunol"},{"key":"2023011217591401600_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2022.01.005","article-title":"Immune system aging and the aging-related diseases in the COVID-19 era","volume":"243","author":"Witkowski","year":"2022","journal-title":"Immunol Lett"},{"issue":"5","key":"2023011217591401600_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/jth.13304","article-title":"Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01\/2010 study","volume":"14","author":"Werwitzke","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2023011217591401600_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jth.14618","article-title":"Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01\/2010 Study","volume":"18","author":"T\u00fcrkantoz","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2023011217591401600_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood-2016-11-751347","article-title":"Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A","volume":"130","author":"Kahle","year":"2017","journal-title":"Blood"},{"key":"2023011217591401600_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"issue":"5-6","key":"2023011217591401600_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.mad.2007.03.001","article-title":"Autoimmunity and longevity: presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians","volume":"128","author":"Hurme","year":"2007","journal-title":"Mech Ageing Dev"},{"issue":"7","key":"2023011217591401600_bib28","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2023011217591401600_bib29","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G\u2217Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"issue":"6","key":"2023011217591401600_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00277-009-0887-3","article-title":"Acquired haemophilia caused by non-haemophilic factor VIII gene variants","volume":"89","author":"Tiede","year":"2010","journal-title":"Ann Hematol"},{"issue":"suppl 3","key":"2023011217591401600_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02259.x","article-title":"Genetic markers in acquired haemophilia","volume":"16","author":"Oldenburg","year":"2010","journal-title":"Haemophilia"},{"issue":"4","key":"2023011217591401600_bib32","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI117489","article-title":"Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies","volume":"94","author":"Gilles","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"2023011217591401600_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2000-9817","article-title":"Natural autoantibodies and anti-idiotypes","volume":"26","author":"Gilles","year":"2000","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2023011217591401600_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2000-9818","article-title":"Natural antibodies to factor VIII","volume":"26","author":"Lacroix-Desmazes","year":"2000","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2023011217591401600_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12815","article-title":"Autoreactive B cells in SLE, villains or innocent bystanders?","volume":"292","author":"Hamilton","year":"2019","journal-title":"Immunol Rev"},{"key":"2023011217591401600_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2018.00016","article-title":"Two distinct pathways in mice generate antinuclear antigen-reactive B cell repertoires","volume":"9","author":"Faderl","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"2023011217591401600_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-020-0173-8","article-title":"Contributions of age-related thymic involution to immunosenescence and inflammaging","volume":"17","author":"Thomas","year":"2020","journal-title":"Immun Ageing"},{"issue":"3","key":"2023011217591401600_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","article-title":"Inflammaging and \u2018Garb-aging\u2019","volume":"28","author":"Franceschi","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2023011217591401600_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1191\/0961203303lu383ed","article-title":"Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly","volume":"12","author":"Ramos-Casals","year":"2003","journal-title":"Lupus"},{"issue":"4","key":"2023011217591401600_bib40","first-page":"217","article-title":"Immunity, autoimmunity and autoimmune diseases in older people","volume":"22","author":"Rosato","year":"2008","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"issue":"9","key":"2023011217591401600_bib41","doi-asserted-by":"crossref","first-page":"102893","DOI":"10.1016\/j.autrev.2021.102893","article-title":"Immunosenescence in multiple sclerosis: the identification of new therapeutic targets","volume":"20","author":"Dema","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2023011217591401600_bib42","doi-asserted-by":"crossref","first-page":"20104","DOI":"10.1038\/srep20104","article-title":"Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1","volume":"6","author":"Landegren","year":"2016","journal-title":"Sci Rep"},{"key":"2023011217591401600_bib43","unstructured":"Tenny\n              S\n            , KerndtCC, HoffmanMR. Case Control Studies. Accessed 16 March 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448143\/."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/1\/122\/2028731\/blooda_adv-2022-008071-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/1\/122\/2028731\/blooda_adv-2022-008071-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T12:59:47Z","timestamp":1673528387000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/1\/122\/486178\/Targets-of-autoantibodies-in-acquired-hemophilia-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008071","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}